NXL Nexalin Technology, Inc.

Nasdaq nexalin.com


$ 1.48 $ -0.03 (-1.95 %)    

Wednesday, 22-Oct-2025 17:04:12 EDT
QQQ $ 604.27 $ -5.89 (-0.96 %)
DIA $ 464.98 $ -3.44 (-0.73 %)
SPY $ 666.76 $ -3.49 (-0.52 %)
TLT $ 92.19 $ 0.06 (0.07 %)
GLD $ 376.01 $ 0.04 (0.01 %)
$ 1.51
$ 1.50
$ 1.40 x 6
$ 1.63 x 10
$ 1.37 - $ 1.57
$ 0.70 - $ 4.49
479,057
na
26.65M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-14-2025 12-31-2024 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-27-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-27-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nexalin-technology-announces-three-independent-peer-reviewed-clinical-studies-along-with-internal-data-show-that-its-15-ma-gen-2-nexalin-difs-technology-can-improve-cognition-restore-brain-activity-and-enhance-neuron-connectivity-in-patients-with-alzheimers-disease

Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency S...

 nexalin-technology-enters-amendment-no-2-to-equity-distribution-agreement-amendment-increases-maximum-shares-offering-price-to-10m

- SEC Filing

 why-is-micro-cap-stock-nexalin-technology-rallying-on-wednesday

Nexalin stock surged as new clinical data showed its Gen-2 device improved cognition and brain connectivity in mild Alzheimer&#...

 nexalin-announces-publication-of-additional-clinical-data-in-radiology-showing-proprietary-15-ma-gen-2-nexalin-difs-technology-improves-cognitive-performance-and-enhances-brain-network-connectivity-in-ad-patients

Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW)) (the "Company" or "Nexalin"), the leader in Deep Intracranial Fre...

 nexalin-secures-15-yr-us-design-patent-for-halo-clarity-neuromodulation-device

Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW)) (the "Company" or "Nexalin"), the leader in Deep Intracranial Fre...

 nexalin-technology-q2-2025-gaap-eps-010-up-from-017-yoy-sales-70588k-up-from-26840k-yoy

Nexalin Technology (NASDAQ:NXL) reported quarterly losses of $(0.10) per share. This is a 41.18 percent increase over losses of...

 nexalin-technology-justin-van-fleet-to-serve-as-cfo-starting-august-1-2025

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION